<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies suggest a powerful prognostic value for plasma cytokine levels in primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (interleukin (IL)-2R, IL-8, IL-12, IL-15 and C-X-C motif chemokine 10 (CXCL10)) and large-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (IL-2R, IL-8, IL-10, IL-12, CXCL9 and CXCL10) </plain></SENT>
<SENT sid="1" pm="."><plain>To examine the possibility of a similar phenomenon in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), we used multiplex enzyme-linked immunosorbent assay to measure 30 plasma cytokines in 78 patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (n = 35), the levels of 19 cytokines were significantly altered </plain></SENT>
<SENT sid="3" pm="."><plain>Multivariable analysis identified increased levels of CXCL10 (P&lt;0.01), IL-7 (P = 0.02) and IL-6 (P = 0.07) as predictors of shortened survival; the survival association remained significant when the Cox model was adjusted for the International Prognostic Scoring System, age, transfusion-need or <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with <z:mpath ids='MPATH_458'>normal</z:mpath> plasma levels of CXCL10, IL-7 and IL-6 lived significantly longer (median survival 76 months) than those with elevated levels of at least one of the three cytokines (median survival 25 months) (P&lt;0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>Increased levels of IL-6 were associated with inferior <z:hpo ids='HP_0001909'>leukemia</z:hpo>-free survival, independent of other prognostic factors (P = 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>Comparison of plasma cytokines between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n = 78) and primary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (n = 127) revealed a significantly different pattern of abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>These observations reinforce the concept of distinct and prognostically relevant plasma cytokine signatures in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
</text></document>